体外膜氧合在无创机械通气的冠状病毒病2019患者中的清醒应用
本文报告1例38岁男性医务人员,诊断为冠状病毒病2019后进展至危重状态,在高流量鼻导管Fio2 100%、流量40 L/min条件下最大血氧饱和度仅88%,并出现严重皮下气肿。为避免正压通气可能加重的气压伤和血流动力学损害,采用清醒体外膜氧合治疗,未行有创机械通气,患者成功救治。作者认为,在经选择的严重呼吸衰竭患者中,清醒体外膜氧合可作为挽救性治疗并避免有创机械通气。
要点
- 38岁男性医务人员冠状病毒病2019进展至危重,高流量鼻导管Fio2 100%、流量40 L/min下最大血氧饱和度88%,并出现严重皮下气肿。
- 为避免正压通气可能加重的气压伤和血流动力学损害,采用清醒体外膜氧合,未行有创机械通气,患者成功救治。
- 作者认为,在经选择的严重呼吸衰竭患者中,清醒体外膜氧合可作为挽救性治疗并避免有创机械通气。
适用人群与场景
- 经选择的严重呼吸衰竭患者,包括冠状病毒病2019进展至危重状态者。
处置流程与药物剂量
- 对1例38岁男性医务人员冠状病毒病2019危重患者,在未行有创机械通气的条件下应用清醒体外膜氧合,以避免正压通气可能加重的气压伤和血流动力学损害。
红旗征与不能漏的情况
- 高流量鼻导管Fio2 100%、流量40 L/min下最大血氧饱和度88%,并出现严重皮下气肿。
研究设计与关键结果
- 本文为病例报告,报告1例38岁男性医务人员冠状病毒病2019危重患者,高流量鼻导管Fio2 100%、流量40 L/min下最大血氧饱和度88%,合并严重皮下气肿。
- 该患者经清醒体外膜氧合成功救治,无需有创机械通气。
- 据作者所知,这是文献中最早报告的将清醒体外膜氧合作为冠状病毒病2019相关严重急性呼吸窘迫综合征所致气压伤的「治疗」、且无需有创机械通气的病例之一。
证据类型、等级与局限
- 证据类型:病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在经选择的严重呼吸衰竭患者中,清醒体外膜氧合可作为挽救性治疗并避免有创机械通气。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES/BACKGROUND: Extracorporeal membrane oxygenation is used as rescue therapy for patients with acute respiratory distress syndrome in whom conventional therapy has failed prior to an Extra Corporeal Membrane Oxygenator to rescue Lung Injury in Severe Acute Respiratory Distress Syndrome trial. Since then, extracorporeal membrane oxygenation has been incorporated as part of the standard treatment algorithm in many centers for patients with severe acute respiratory distress syndrome. Since the emergence of coronavirus disease 2019 in early 2020, extracorporeal membrane oxygenation has been used effectively as rescue therapy and as a bridge to recovery in some patients with refractory respiratory failure.
DESIGN SUBJECT AND INTERVENTION: We present a 38-year-old male healthcare worker diagnosed with coronavirus disease 2019 and progressed to critical condition with severe surgical emphysema on a high-flow nasal cannula with Fio2 100%, a flow of 40 L/min, and a maximum oxygen saturation of 88%. He was successfully treated by applying awake extracorporeal membrane oxygenation, without a need for invasive mechanical ventilation, to avoid worsening barotrauma and hemodynamic compromise potentially induced by positive pressure ventilation.
MAIN RESULTS AND CONCLUSIONS: To our knowledge, this is one of the first cases to be reported in the literature on the use of awake extracorporeal membrane oxygenation as a "treatment" for barotrauma due to severe acute respiratory distress syndrome in a coronavirus disease 2019 patient, without the need for invasive mechanical ventilation. In selected patients with severe respiratory failure, awake extracorporeal membrane oxygenation can be used as a salvage treatment and obviate the need for invasive mechanical ventilation.
参考来源
- Azzam MH, Mufti HN, Bahaudden H, et al. Awake Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019 Patients Without Invasive Mechanical Ventilation. Crit Care Explor. 2021. PMID: 34104895. doi:10.1097/CCE.0000000000000454
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。